期刊文献+

奥卡西平治疗儿童局限性癫癎64例 被引量:5

Treatment of Partial Epilepsy with Oxcarbazepine in 64 Children
下载PDF
导出
摘要 目的观察奥卡西平(OXC)治疗儿童局限性癫癎的疗效和不良反应,并作出评价。方法局限性癫癎患儿64例,41例新诊断或未经正规抗癫癎治疗需用OXC单药治疗的患儿进入OXC单药治疗组;23例曾使用一种或多种抗癫癎药物治疗,目前仍需联合应用OXC进行抗癫癎治疗的患儿进入OXC添加治疗组。OXC治疗的起始剂量为4~8 mg/(kg·d),每隔1周增加1次剂量,每次增加不超过10 mg/(kg·d),维持剂量28~40 mg/(kg·d),分2次服用。进行自身对比开放性观察,分析二组6个月内的疗效及不良反应。结果本组中单药治疗组、添加治疗组、全组的总有效率分别为85.4%、69.6%、79.7%,其完全控制率分别为53.7%、17.4%、40.6%。单药治疗与添加治疗组6个月后总有效率比较有显著性差异(P〈0.05);单药治疗组2、4、6个月总有效率比较无显著性差异(Pa〉0.05)。最常见的不良反应:皮疹7例,嗜睡、头晕各3例,乏力2例,低钠血症、恶心纳差各1例。因皮疹退出6例(9.4%),停药及对症处理后,均恢复正常。结论OXC治疗儿童局限性癫癎疗效确切、耐受性好、不良反应轻。 Objective To evaluate the efficacy and adverse events of oxcarbazepine(OXC) on the children with partial epilepsy. Methods Sixty - four children with partial epilepsy were divided into 2 groups. Forty - one newly diagnosed patients who had never accepted standard therapy entered monotherapy group, and 23 patients who had many anti -epileptic drug(AEDs) in turn with poor efficacy served as add -on therapy group. The initial dose was 4 -8 mg/( kg·d). The dosage was increased by one time every 2 weeks, and should not exceed 10 mg/( kg·d) in each time. The maintenance dose was 28 - 40 mg/( kg·d ). With open - label autocontrol method, the efficacy and adverse events of OXC were analyzed during the first 6 months of treatment both in 2 groups. Results The effective rates were 85.4% ,69.6% and 79.7% ,in monotherapy,add -on therapy and total groups. The seizure free rates were 53.7% ,17.4% and 40.6%. It showed that the seizure frequencies between 2 groups at 6 months after therapy were significantly difference( P 〈 0.05 ). However,there were no signi-fieantly differences at 2,4 and 6 months after therapy in monotherapy group(Pa 〉 0.05 ). The common adverse events were dizziness,headache,fatigue and nausea. SIX patients had dropped out because of rashes,however, they all recovered after drug withdrawal and nonspeeific therapy. Conclusion The efficacy of OXC is sustained with good safety and tolerability profiles on the treatment of children patients with partial epilepsy.
作者 梁超 郑帼
出处 《实用儿科临床杂志》 CAS CSCD 北大核心 2008年第7期537-538,共2页 Journal of Applied Clinical Pediatrics
关键词 奥卡西平 癫癎 局限性 疗效 不良反应 儿童 oxcarbazepine epilepsies, partial efficacy adverse events child
  • 相关文献

参考文献7

二级参考文献59

  • 1潘映辐,姬长莲,陈葵,周立春.拉莫三嗪对难治性癫痫的临床观察[J].临床神经病学杂志,1996,9(2):94-97. 被引量:11
  • 2吴逊.癫痫和发作性疾病[M].北京:人民军医出版社,2001.110.
  • 3Farber NB, Jiang XP, Heinkel C, et al. Antiepileptic drugs and agents that inhibit voltage-gated sodium channels prevent NMDA antagonist neurotoxicity [J]. Mol Psychiatry, 2002, 7(7): 726-733.
  • 4Angehagen M, Ben-Menachem E, Ronnback L, et al.Novel mechanisms of action of three antiepileptic drugs,vigabatrin, tiagabine, and topiramate[J]. Neurochem Res,2003, 28(2):333-340.
  • 5Rose MA, Kam PC. Gabapentin: pharmacology and its use in pain management[J]. Anaesthesia, 2002, 57(5):451-462.
  • 6McLean MJ. Clinical pharmacokinetics of gabapentin[J].Neurology, 1994, 44(6 Suppl 5): S17-S22.
  • 7Wu WN, Heebner JB, Streeter A J, et al. Evaluation of the absorption, excretion, pharrnacokinetics and metabolism of anticonvulsant topiramate in healthy men [J].Pharm Res, 1994, 11(10 Suppl): S336.
  • 8Browne TR. Pharmacokinetics of antiepileptic drugs[J].Neurology, 1998, 51(5 Suppl 4):S2-S7.
  • 9Perucca E. The clinical pharmacokinetics of the new antiepileptic drugs[J]. Epilepsia, 1999, 40(Suppl 9):S7-S13.
  • 10Perucca E, Johannessen SI. The ideal pharmacokinetic properties of an antiepileptic drug: how close does leve tiracetam come[J]? Epileptic Disord, 2003, 5(Suppl 1):S17-S26.

共引文献39

同被引文献40

  • 1俞雅珍,田朝霞,高宝勤,杨伟力.奥卡西平治疗儿童难治性癫痫的自身对照性研究[J].首都医科大学学报,2007,28(3):382-384. 被引量:7
  • 2许虹,孙超艳,杨佳,徐国卫.拉莫三嗪对癫痫大鼠的脑电图及Bax、Bcl-2表达的影响[J].山东大学学报(医学版),2007,45(7):681-684. 被引量:7
  • 3Leskiewicz M, Budziszewska B, Lason W. Endocrine effects of antiepileptic drugs [ J ]. Przegl Lek, 2008,65 ( 11 ) : 795 - 798.
  • 4Kothare SV, Kaleyias J. The adverse effects of antiepileptic drugs in children[J]. Expert Opin Drug Saf,2007,6(3) :251 -265.
  • 5Verrotti A, Scardapane A, Manco R,et al. Antiepileptic drugs and thyroid function [ J ]. J Pediatr Endocrinol Metab, 2008,21 ( 5 ) :401 - 408.
  • 6McHugh JC, Delanty N. Epidemiology and classification of epilepsy: Gender comparisons [ J ]. Int Rev Neurobiol,2008,83 : 11 - 26.
  • 7Cansu A,Serdaroglu A,Camurdan O,et al. The evaluation of thyroid functions, thyroid antibodies, and thyroid volumes in children with epilepsy during short - term administration of oxcarbazepine and valpmate[ J]. Epilepsia, 2006,47 ( 11 ) : 1855 - 1859.
  • 8Vainionpaa LK, Mikkonen K, Rattya J, et al. Thyroid function in girls with epilepsy with carbamazepine, oxcarbazepine, or valproate monotherapy and after withdrawal of medication [ J ]. Epilepsia, 2004,45 ( 3 ) : 197 - 203.
  • 9Hirfanoglu T, Serdaroglu A, Camurdan O, et al. Thyroid function and volume in epileptic children using carbamazepine, oxcarbazepine and valproate[ J]. Pediatr lnt, 2007,49(6) :822 - 826.
  • 10Ronzon - Feruondez A, Macia - Bobes C. Low serum free thyroxine concentration in a patient treated with oxcarbazepine [ J ]. Rev Neurol, 2006,42 ( 7 ) :444.

引证文献5

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部